Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

PIK will build a large industrial park in Balashikha

2/27/25 PIKK

Medsi is preparing to open its first clinic abroad

2/27/25 AFKS

Moscow Exchange started trading in the first fund for platinum and palladium

2/26/25 MOEX

M.Combo has already been issued to more than 100 thousand buyers of M.Video-Eldorado

2/26/25 MVID

Rostelecom reported for 2024 by IFRS

2/26/25 RTKM

EU postpones introduction of a mechanism for tracking Russian diamonds

2/26/25 ALRS

Yandex launches SourceCraft development platform

2/26/25 YDEX

Cherkizovo develops cooperation with partners from China and Serbia

2/26/25 GCHE

Phosagro increased exports by 33%

2/25/25 PHOR

Yandex has introduced YandexGPT 5

2/25/25 YDEX